Holler E - Search Results

1

Improved survival following HLA-incompatible bone marrow transplantation. Munich Cooperative Group of Bone Marrow Transplantation.

Kolb HJ, Bender-Götze C, Holler E, Mittermüller J, Grosse-Wilde H, Wank R, Eckstein R, Scholz S, Haas RJ, Mempel W, et al. Kolb HJ, et al. Among authors: holler e. Folia Haematol Int Mag Klin Morphol Blutforsch. 1989;116(3-4):421-5. Folia Haematol Int Mag Klin Morphol Blutforsch. 1989. PMID: 2480284

2

Bone marrow transplantation for the treatment of leukaemia-results of the Munich Cooperative Group.

Kolb HJ, Bender-Götze C, Haas RJ, Holler E, Thierfelder S, Wilmanns W. Kolb HJ, et al. Among authors: holler e. Folia Haematol Int Mag Klin Morphol Blutforsch. 1989;116(3-4):397-402. Folia Haematol Int Mag Klin Morphol Blutforsch. 1989. PMID: 2480280 Clinical Trial.

3

Myeloablative conditioning for marrow transplantation in myelodysplastic syndromes and paroxysmal nocturnal haemoglobinuria.

Kolb HJ, Holler E, Bender-Götze C, Walther U, Mittermüller J, Clemm C, Bauchinger M, Gerhartz HH, Brehm G, Ledderose G, et al. Kolb HJ, et al. Among authors: holler e. Bone Marrow Transplant. 1989 Jan;4(1):29-34. Bone Marrow Transplant. 1989. PMID: 2647184

4

Adoptive immunotherapy with donor lymphocyte transfusions.

Kolb HJ, Holler E. Kolb HJ, et al. Among authors: holler e. Curr Opin Oncol. 1997 Mar;9(2):139-45. doi: 10.1097/00001622-199703000-00006. Curr Opin Oncol. 1997. PMID: 9161791 Review.

5

Hematopoietic transplantation: state of the art.

Kolb HJ, Holler E. Kolb HJ, et al. Among authors: holler e. Stem Cells. 1997;15 Suppl 1:151-7; discussion 158. doi: 10.1002/stem.5530150819. Stem Cells. 1997. PMID: 9368335 Review.

6

Treatment of aGVHD with OKT3: clinical outcome and side-effects associated with release of TNF alpha.

Gleixner B, Kolb HJ, Holler E, Liesenfeld S, Riedner C, Hiller E, Seeber C, Kempeni J, Möller A, Knabe H, et al. Gleixner B, et al. Among authors: holler e. Bone Marrow Transplant. 1991 Aug;8(2):93-8. Bone Marrow Transplant. 1991. PMID: 1933064

7

Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients.

Kolb HJ, Mittermüller J, Clemm C, Holler E, Ledderose G, Brehm G, Heim M, Wilmanns W. Kolb HJ, et al. Among authors: holler e. Blood. 1990 Dec 15;76(12):2462-5. Blood. 1990. PMID: 2265242 Free article.

8

Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation.

Holler E, Kolb HJ, Möller A, Kempeni J, Liesenfeld S, Pechumer H, Lehmacher W, Ruckdeschel G, Gleixner B, Riedner C, et al. Holler E, et al. Blood. 1990 Feb 15;75(4):1011-6. Blood. 1990. PMID: 2405918 Free article.

9

Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation.

Holler E, Kolb HJ, Hiller E, Mraz W, Lehmacher W, Gleixner B, Seeber C, Jehn U, Gerhartz HH, Brehm G, et al. Holler E, et al. Blood. 1989 May 15;73(7):2018-24. Blood. 1989. PMID: 2496776 Free article.

10

[Therapy of a patient with graft versus host reaction following allogenic bone marrow transplantation with the monoclonal antibody OKT3 (Orthoclone OKT3)].

Jung G, Holler E, Kolb HJ, Wilmanns W. Jung G, et al. Among authors: holler e. Internist (Berl). 1989 Jun;30(6):386-8. Internist (Berl). 1989. PMID: 2503460 German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

616 results

Search Page

Filters